Calculating Respiration Parameters Using Impedance Plethysmography

• US 20090118626A1
• Filed: 11/01/2007
• Published: 05/07/2009
• Est. Priority Date: 11/01/2007
• Status: Abandoned Application

• Current Assignee: Data Sciences U K Limited (International Business Machines Corporation)
• Original Assignee: Transoma Medical, Inc.
• Inventors: Belalcazar, Andres, Haefner, Paul, Moon, Loell Boyce
• Application Number:
  US11/933,872
• Publication Number:
  US 20090118626A1
• Time in Patent Office: Days
• US Class Current: 600/484
• CPC Class Codes: A61B 5/0535 Impedance plethysmography for measuring blood flow A61B5/0295
• CPC Class Codes: A61B 5/0809 by impedance pneumography

Abstract

A method of determining a value for a respiration parameter in a test subject can include capturing—using a fully implanted system that includes a wireless transmitter and at least a first lead wire having a first electrode disposed thereon and a second lead wire having a second electrode disposed thereon—information indicative of an impedance measure between the first and second electrodes and across a thoracic region of the test subject; wirelessly transmitting, from the implanted system and to external equipment, the captured information; and determining a respiration parameter of the test subject based on the captured information. The at least first and second lead wires can be positioned in the test subject subcutaneously and external of any cranial, thoracic, abdominal and pelvic cavities of the test subject

Claims

1. A method of determining a value for a respiration parameter in a test subject, the method comprising:

capturing—

using a fully implanted system that is comprised of a wireless transmitter and at least a first lead wire having a first electrode disposed thereon and a second lead wire having a second electrode disposed thereon, wherein the at least first and second lead wires are positioned in the test subject subcutaneously and external of any cranial, thoracic, abdominal and pelvic cavities of the test subject—

information indicative of an impedance measure between the first and second electrodes and across a thoracic region of the test subject;

wirelessly transmitting, from the implanted system and to external equipment, the captured information;

determining in the external equipment a value for a respiration parameter of the test subject based on the wirelessly transmitted information; and

using the determined respiration parameter in safety pharmacology testing or toxicity testing to assess impact of a pharmaceutical compound on the test subject'"'"'s respiratory system.

2. A method of determining a value for a respiration parameter in a test subject, the method comprising:

capturing—

using a fully implanted system that is comprised of a wireless transmitter and at least a first lead wire having a first electrode disposed thereon and a second lead wire having a second electrode disposed thereon, wherein the at least first and second lead wires are positioned in the test subject subcutaneously and external of any cranial, thoracic, abdominal and pelvic cavities of the test subject—

information indicative of an impedance measure between the first and second electrodes and across a thoracic region of the test subject;

wirelessly transmitting, from the implanted system and to external equipment, the captured information; and

determining a respiration parameter of the test subject based on the captured information.

3. The method of claim 2, wherein the electrodes are positioned in the test subject such that the impedance measure between the electrodes is made across the thoracic region of the test subject in manner that crosses a sagittal plane of the test subject in a cranial-to-caudal or posterior-to-inferior manner.

4. The method of claim 2, wherein the electrodes are positioned in the test subject such that the impedance measure between the electrodes is made through at least a portion of one of the test subject'"'"'s lungs.

5. The method of claim 2, wherein the transmitter is positioned subcutaneously and external of any cranial, thoracic, abdominal and pelvic cavities of the test subject.

6. The method of claim 2, wherein capturing the information indicative of the impedance measure comprises injecting a current between two electrodes and measuring a resulting voltage between two electrodes.

7. The method of claim 6, wherein the fully implanted system comprises four electrodes, and wherein the two electrodes between which current is injected and the two electrodes between which the resulting voltage is measured are each distinct electrodes.

8. The method of claim 6, wherein the captured information comprises a value for the measured resulting voltage.

9. The method of claim 2, wherein the test subject is selected from the group of laboratory animals consisting of rodents, bovines, canines, ovines, porcines and non-human primates.

10. The method of claim 2, wherein the test subject is a human patient.

11. The method of claim 2, wherein the impedance measure comprises a base impedance component and a modulated impedance component, and wherein determining the respiration parameter comprises normalizing the modulated impedance component relative to the base impedance component.

12. The method of claim 2, wherein determining the respiration parameter of the test subject based on the captured information comprises identifying in the captured information first periodic data having a first dominant frequency and second periodic data having a second dominant frequency that is lower than the first frequency, and determining the respiration parameter of the test subject based on the second periodic data.

13. The method of claim 12, wherein the fully implanted system comprises a pressure sensor configured to obtain blood pressure information from the test subject, and wherein identifying in the captured information the first periodic data comprises identifying the first periodic data based on the blood pressure information.

14. The method of claim 12, wherein the fully implanted system comprises a sensor configured to obtain electrocardiogram (ECG) data from the test subject, and wherein identifying in the captured information the first periodic data comprises identifying the first periodic data based on the ECG data.

15. The method of claim 12, further comprising:

identifying in the captured information third data having spectral content that indicates that the third data has been corrupted by at least one of the test subject'"'"'s posture or the test subject'"'"'s activity; and

removing the third data from the captured information.

16. The method of claim 15, wherein the fully implanted system comprises an accelerometer sensor, and wherein identifying in the captured information the third data comprises identifying the third data based on data from the accelerometer sensor.

17. The method of claim 15, wherein the fully implanted system comprises an electromyogram (EMG) sensor, and wherein identifying in the captured information the third data comprises identifying the third data based on data from the EMG sensor.

18. The method of claim 2, wherein capturing the information indicative of the impedance measure comprises capturing the information when the test subject is unrestrained and unanesthetized.

19. The method of claim 2, further comprising using the determined respiration parameter in safety pharmacology testing or toxicity testing to assess impact of a pharmaceutical compound on the test subject'"'"'s respiratory system.

20. The method of claim 2, wherein determining the value for the respiration parameter of the test subject comprises determining a tidal volume, the method further comprising measuring tidal volume of the test subject with a device that is external to the test subject, and calibrating a relationship between the captured information and the measured tidal volume.

21. The method of claim 20, wherein determining the value for the tidal volume of the test subject comprises correlating the captured information with the tidal volume based on the calibrated relationship.

22. The method of claim 21, wherein the calibrated relationship is a function of mass of the test subject, the method further comprising normalizing the tidal volume based on a mass of the test subject.

23. The method of claim 2, wherein determining the value for the respiration parameter of the test subject comprises identifying a time-ordered sequence of impedance values in the captured information, and determining, based on the time-ordered sequence of impedance values, at least one of a tidal volume, an inspiratory time, an expiratory time, an inspiratory flow or an expiratory flow of the test subject.

24. The method of claim 2, wherein the fully implanted system further comprises a pressure sensor, the method further comprising capturing, with the pressure sensor, information indicative of an internal pressure of the test subject.

25. An implantable device configured to monitor thoracic impedance in a test subject, the implantable device comprising:

a fully implantable system that is comprised of controller and at least a first lead wire and a second lead wire, wherein the controller and the first and second lead wires are configured to be subcutaneously implanted in the test subject, external of any cranial, thoracic, abdominal or pelvic cavities of the test subject;

wherein, the first lead wire has first and second electrodes disposed thereon and the second lead wire has third and fourth electrodes disposed thereon; and

wherein the controller comprises a) a current signal generator that generates a current signal between the first and third electrodes;

b) a voltage amplifier that detects a voltage difference between the second and fourth electrodes; and

c) a wireless transmitter that is configured to transmit information to external equipment when the test subject is ambulatory and unanesthetized, the information comprising the detected voltage difference or a signal derived from the detected voltage difference.